Inflammatory Bowel Disease (IBD) cases are increasing in Indonesia, according to a 2026 update from the Indonesian Bowel Disease Association. The report highlights a steady rise in both ulcerative colitis and Crohn’s disease diagnoses across the country. Despite this growth, public awareness remains low, with many Indonesians unaware of the symptoms or risk factors associated with IBD.
The report emphasizes the gap between rising incidence and limited access to early diagnosis. Many patients seek treatment only after symptoms become severe, leading to delayed care and more complex treatments. Experts warn that without improved public education and better healthcare infrastructure, the burden of IBD could continue to grow.
Health officials note that cultural and socioeconomic factors contribute to the delay in seeking medical help. There is also a lack of specialized IBD clinics in many regions, forcing patients to travel long distances for treatment. The association is now pushing for national campaigns to raise awareness and improve early detection.
The situation underscores the need for stronger government and private sector collaboration to address the growing health challenge. With more cases expected in the coming years, experts stress that action is needed now to prevent further strain on Indonesia’s healthcare system.
